137 related articles for article (PubMed ID: 6818344)
1. Spiro oxazolidinedione aldose reductase inhibitors.
Schnur RC; Sarges R; Peterson MJ
J Med Chem; 1982 Dec; 25(12):1451-4. PubMed ID: 6818344
[TBL] [Abstract][Full Text] [Related]
2. Spiro hydantoin aldose reductase inhibitors.
Sarges R; Schnur RC; Belletire JL; Peterson MJ
J Med Chem; 1988 Jan; 31(1):230-43. PubMed ID: 3121857
[TBL] [Abstract][Full Text] [Related]
3. Spiro hydantoin aldose reductase inhibitors derived from 8-aza-4-chromanones.
Sarges R; Goldstein SW; Welch WM; Swindell AC; Siegel TW; Beyer TA
J Med Chem; 1990 Jul; 33(7):1859-65. PubMed ID: 2113948
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and aldose reductase inhibitory activity of 2-substituted-6-fluoro-2,3-dihydrospiro [4H-1-benzopyran-4, 4'-imidazolidine]-2',5'-diones.
Yamaguchi T; Miura K; Usui T; Unno R; Matsumoto Y; Fukushima M; Mizuno K; Kondo Y; Baba Y; Kurono M
Arzneimittelforschung; 1994 Mar; 44(3):344-8. PubMed ID: 8192700
[TBL] [Abstract][Full Text] [Related]
5. Isoxazolidine-3,5-diones as lens aldose reductase inhibitors.
Richon AB; Maragoudakis ME; Wasvary JS
J Med Chem; 1982 Jun; 25(6):745-7. PubMed ID: 6808134
[No Abstract] [Full Text] [Related]
6. Inhibition of aldose reductases from rabbit lens by oxazole derivatives.
Tanimoto T; Fukuda H; Kawamura J; Nakao M; Shimada U; Yamada A; Tanaka C
Chem Pharm Bull (Tokyo); 1984 Mar; 32(3):1032-9. PubMed ID: 6430576
[No Abstract] [Full Text] [Related]
7. Sorbinil: a member of the novel class of spirohydantoin aldose reductase inhibitors.
Sarges R; Peterson MJ
Metabolism; 1986 Apr; 35(4 Suppl 1):101-4. PubMed ID: 3083199
[TBL] [Abstract][Full Text] [Related]
8. Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1.
Malamas MS; Hohman TC; Millen J
J Med Chem; 1994 Jun; 37(13):2043-58. PubMed ID: 8027986
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and aldose reductase inhibitory activity of 2-substituted 6-fluoro-2,3-dihydrospiro[4H-1-benzopyran-4,4'-imidazolidine]-2',5'-dio nes.
Unno R; Yamaguchi T; Usui T; Kakigami T; Fukushima M; Mizuno K; Baba Y; Kurono M
Chem Pharm Bull (Tokyo); 1994 Jul; 42(7):1474-8. PubMed ID: 7923471
[TBL] [Abstract][Full Text] [Related]
10. Studies on antidiabetic agents. IX. A new aldose reductase inhibitor, AD-5467, and related 1,4-benzoxazine and 1,4-benzothiazine derivatives: synthesis and biological activity.
Tawada H; Sugiyama Y; Ikeda H; Yamamoto Y; Meguro K
Chem Pharm Bull (Tokyo); 1990 May; 38(5):1238-45. PubMed ID: 2118427
[TBL] [Abstract][Full Text] [Related]
11. Medicinal chemistry of aldose reductase inhibitors.
Larson ER; Lipinski CA; Sarges R
Med Res Rev; 1988; 8(2):159-86. PubMed ID: 3132580
[No Abstract] [Full Text] [Related]
12. Orally active aldose reductase inhibitors derived from bioisosteric substitutions on tolrestat.
Wrobel J; Millen J; Sredy J; Dietrich A; Kelly JM; Gorham BJ; Sestanj K
J Med Chem; 1989 Nov; 32(11):2493-500. PubMed ID: 2509709
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and aldose reductase-inhibitory activities of structural analogues of WF-3681, a novel aldose reductase inhibitor.
Namiki T; Baba Y; Suzuki Y; Nishikawa M; Sawada K; Itoh Y; Oku T; Kitaura Y; Hashimoto M
Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1404-14. PubMed ID: 3138031
[No Abstract] [Full Text] [Related]
14. Computer-assisted design and synthesis of novel aldose reductase inhibitors.
Butera J; Bagli J; Doubleday W; Humber L; Treasurywala A; Loughney D; Sestanj K; Millen J; Sredy J
J Med Chem; 1989 Apr; 32(4):757-65. PubMed ID: 2539477
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of aldose reductase from rat nervous tissue by metabolites of cyclandelate.
Van den Hoven WE; Hall DW; Burns JW
Br J Clin Pract Suppl; 1984; 34():31-3. PubMed ID: 6430320
[No Abstract] [Full Text] [Related]
16. Novel, highly potent aldose reductase inhibitors: (R)-(-)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4- tetrahydropyrrolo[1,2-a]pyrazine -4-spiro-3'-pyrrolidine-1,2',3,5'-tetrone (AS-3201) and its congeners.
Negoro T; Murata M; Ueda S; Fujitani B; Ono Y; Kuromiya A; Komiya M; Suzuki K; Matsumoto J
J Med Chem; 1998 Oct; 41(21):4118-29. PubMed ID: 9767647
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and aldose reductase-inhibitory activity of benzo[b]furan derivatives possessing a carboxymethylsulfamoyl group.
Ohishi Y; Mukai T; Nagahara M; Yajima M; Kajikawa N
Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2398-405. PubMed ID: 2514045
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity studies of aldose reductase inhibitors containing the 4-oxo-4h-chromen ring system.
Kador PF; Sharpless NE
Biophys Chem; 1978 Mar; 8(1):81-5. PubMed ID: 417745
[TBL] [Abstract][Full Text] [Related]
19. Effects of a new aldose reductase inhibitor on various tissues in vitro.
Terashima H; Hama K; Yamamoto R; Tsuboshima M; Kikkawa R; Hatanaka I; Shigeta Y
J Pharmacol Exp Ther; 1984 Apr; 229(1):226-30. PubMed ID: 6423811
[TBL] [Abstract][Full Text] [Related]
20. Studies on WF-3681, a novel aldose reductase inhibitor. II. Structure determination and synthesis.
Namiki T; Nishikawa M; Itoh Y; Uchida I; Hashimoto M
J Antibiot (Tokyo); 1987 Oct; 40(10):1400-7. PubMed ID: 3119548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
